Lisa schwartz md

Lisa schwartz md DEFAULT

Experience and Background Checks

Background Check

No malpractice claims found for Colorado

No disciplinary actions found for the years we collect data

No board actions found for the years we collect data

Learn more about background checks

Accepted insurance can change. Please double-check when making an appointment.

(720) 743-7482

Dr. Schwartz accepts the following insurance:

Aetna HMO
Choice Plus POS II

Balanced Pathway-CO EPO
Balanced Pathway-CO HMO
Balanced-CO PPO
Blue Priority-CO HMO
Blue Priority-CO PPO
Bronze Colorado PPO
Bronze Pathway (Pathway / Individual)-CO HMO
Bronze Pathway (Pathway / Small Grp)-CO HMO
Bronze Pathway w/HSA-CO EPO
Bronze Pathway X (Pathway / Individual)-CO HMO
Bronze Pathway-CO EPO
Catastrophic (Individual)-CO PPO
Catastrophic Pathway (Pathway / Individual)-CO HMO
Catastrophic Pathway X (Pathway / Individual)-CO HMO
CO Pathway (Select Network)-CO
Colorado College-CO
Colorado HMO
Colorado POS
Colorado PPO
CSU Fort Collins-CO
CU Health Plan - Extended-CO
CU Health Plan - High Deductible/HSA Compatible-CO
CU Health Plan - Medicare-CO
CU Health Plans Exclusive-CO HMO
Gold Colorado PPO
Gold Pathway (Pathway / Individual)-CO HMO
Gold Pathway (Pathway / Small Grp)-CO HMO
Gold Pathway w/HSA-CO EPO
Gold Pathway X (Pathway / Individual)-CO HMO
Gold Pathway-CO EPO
Healthy Blue Priority 1-CO HMO
Healthy Blue Priority with HSA 1-CO
Healthy Support 1-CO PPO
Healthy Support with HSA 1-CO PPO
Indemnity (Traditional)-CO
Lumenos plans-CO
Lumenos-CO PPO
National (BlueCard Basic) PPO
National (BlueCard) PPO
Pathway PPO/EPO-CO
Pathway-CO HMO
Platinum Pathway (Pathway / Small Grp)-CO HMO
Platinum Pathway-CO EPO
Platinum-CO PPO
Silver Pathway (Pathway / Individual)-CO HMO
Silver Pathway (Pathway / Small Grp)-CO HMO
Silver Pathway w/HSA-CO EPO
Silver Pathway X (Pathway / Individual)-CO HMO
Silver Pathway-CO EPO
Silver-CO PPO
Traditional Network-CO
University of Colorado Extended PPO
University of Colorado High Deductible PPO
University of Colorado Medicare-CO
WellChoice - C (Select Network)-CO
WellChoice - C-CO
WellChoice - H (Select Network)-CO
WellChoice - H-CO
WellChoice - U (Select Network)-CO
WellChoice - U-CO

Anthem Blue Cross Blue Shield
Anthem Blue Cross Blue Shield PPO

Blue Cross Blue Shield
Blue Card PPO

CareFirst Blue Cross Blue Shield
HealthyBlue 2.0
HealthyBlue Advantage

Cigna HMO
Cigna PPO
Open Access Plus

First Health (Coventry Health Care)
First Health (Coventry Health Care) PPO

Choice Care PPO

MultiPlan PPO
PHCS Network PPO

United Healthcare

About Me


Dr. Lisa Schwartz, MD is a Pediatrics Specialist in Denver, CO. She is affiliated with Rose Medical Center. She is accepting new patients and has indicated...Read more


Baylor Affiliated Hospitals Program

Residency Hospital

Chicago Medical School

Medical School


Northwestern Center Feinberg School of Medicine

Undergraduate School

Frequently Asked Questions


Lisa C. Schwartz, MD


Board Certifications
  • American Board of Internal Medicine - Internal Medicine, 2004
Education and Training
  • Fellowship, University of Toronto, Hospital Medicine, 2012
  • Residency, St. Vincent's Hospital & Medical Center, Internal Medicine, 2004
  • MD from Mount Sinai School of Medicine, 2001

Insurance Plans Accepted

This provider accepts the following insurance plans.

  • Aetna
    • Aetna HMO
    • Aetna Indemnity
    • Aetna Medicare
    • Aetna POS
    • Aetna PPO/EPO
  • Agewell
  • Amidacare
  • Centerlight
  • Cigna
  • ElderPlan
  • Emblem
    • Emblem Select Care Exchange
  • Empire Blue Cross Blue Shield
    • Empire Blue Cross Blue Shield EPO
    • Empire Blue Cross Blue Shield HMO
    • Empire Blue Cross Blue Shield HealthPlus
    • Empire Blue Cross Blue Shield HealthPlus Essential
    • Empire Blue Cross Blue Shield Indemnity
    • Empire Blue Cross Blue Shield MediBlue
    • Empire Blue Cross Blue Shield POS
    • Empire Blue Cross Blue Shield PPO
  • Fidelis
    • Fidelis Child Health
    • Fidelis Essential
    • Fidelis Exchange
    • Fidelis Medicaid
    • Fidelis Medicare
  • GHI
  • Oxford
    • Oxford Freedom
    • Oxford Liberty
    • Oxford Medicare
  • Railroad Medicare
  • Senior Whole Health
  • Tricare
  • UHC
    • UnitedHealthcare EPO
    • UnitedHealthcare HMO
    • UnitedHealthcare Medicare
    • UnitedHealthcare POS
    • UnitedHealthcare PPO
    • UnitedHealthcare Top Tier
  • UPN
  • US
  • VNS
    • Visiting Nurse Service (VNS) Medicare
  • Village Caremax
  • WellCare
View All Accepted PlansThis list of insurances changes regularly, and insurance plans listed may not be accepted at all office locations for this provider. Before your appointment, please confirm with your insurance company that this provider accepts your insurance.
  1. Bohemian hand tattoos
  2. Foreign correspondent salary
  3. Duramax leveling kit


  • B.S., Cornell University, 1990
  • M.S., University of Pittsburgh, 1992
  • EdD, George Washington University, 2010


Dr. Lisa Schwartz is an education professional with more than 25 years of experience in the higher education and healthcare industries conducting program, curriculum, student, and faculty development, marketing, grant writing, and quantitative and qualitative research. Since joining the SMHS faculty, she has served in a number of leadership roles, including as founding director of the Post-baccalaureate Pre-medicine Certificate Program and as the Associate Director of the Research Education, Training and Career Development (RETCD) component of the Clinical and Translational Science Institute at Children’s National (CTSI-CN), an NIH-funded, $20 million collaborative initiative between The George Washington University and Children’s National Medical Center (CNMC).

Previously, Dr. Schwartz was a Senior Education Specialist with the College of Professional Studies (CPS) at The George Washington University where she supported the marketing and recruitment of graduate programs within CPS and the Graduate School of Education and Human Development.

Prior to coming to GW, Dr. Schwartz was the director of the Master’s in Genetic Counseling (MGC) Program at the University of Maryland School of Medicine where she led the planning, organization, administration, evaluation, and delivery of the educational and clinical activities of the training program. She was also the co-principal investigator on two HRSA-funded grants, Interdisciplinary Healthcare Training and Delivery and Genetic Interdisciplinary Faculty Training Program (GIFT) of Duke University. Dr. Schwartz is certified by the American Board of Genetic Counseling (ABGC).


1. Principal investigator, June 1, 2021 – May 31, 2022; 2% in kind
Impact of English Language Proficiency on Online Science-based Examination Performance.
Funded by the Center for Faculty Excellence, GW School of Medicine and Health Sciences ($9,995)
Prospective study of relationship between English language proficiency and background on performance on online science-based examinations, including qualitative interviews of ELL on learning strategies and barriers in an online environment.
2. Principal investigator, January 1, 2021 – June 30, 2022; 9% effort
Exploration of the Need for Additional Credentialing for Laboratory-based Genetic Counselors.
Funded by the American Board of Genetic Counseling ($30,000)
Using a two-phase, mixed method approach, the practice-based competencies needed for entry-level genetic counselors working in a laboratory setting will be explored, as well as the preferred method of obtaining these competencies.
3. Principal investigator, Spring 2017; 5% effort, in kind
Lights, Camera, Action Developing Pre-Health Professional Student
Career Development through Film
Funded by the GW Faculty and Staff Innovation Grant – Shenkman Career Services Fund, The George Washington University ($1,469)
Collaborating with faculty from the GW School of Nursing and GW Disability Support Services, launched a Pre-health Professional Film Series on the GW Virginia Science and Technology Campus.
4. Co-investigator, November 2015 – June 2016 – 5% effort, in kind.
What’s Your Style: Enhancing Interprofessional Communication using the Communication Wheel
Funded by the GW Faculty and Staff Innovation Grant – Shenkman Career Services Fund, The George Washington University Practice ($1,307)
In collaboration with faculty of GW School of Nursing (SON) and an industry coach from GW’s Center for Career Services (CCS), developed, implemented and evaluated an interactive, interprofessional program to enhance interprofessional communication among pre-medicine and nursing students

5. Co-investigatorNovember 2014 – October 2015; 5% effort, in kind per year
Assessing Collaboration Readiness: A Model for Understanding Individual Motivation and Deterrents to Team Collaboration (the Motivation Assessment for Team Readiness, Integration, and Collaboration MATRICx survey)
Funded by GW Health Sciences Emerging Scholars Pilot Grant Program, George Washington University ($10,004).
Collaborating with investigators in the SMHS Department of Clinical Research and Leadership, developed instrument to assess an individual’s level of motivation to participate in teams, the MATRICx, which has been converted into a self-scoring instrument and mobile application.

6. Principal investigator, June 2013- May 2014 - 5% effort in kind, for year. 
Mentored Experience To Expand Opportunities in Research (METEOR) Program,
Funded by GW Office of Diversity and Inclusion, Innovation in Diversity and Inclusion (IDI) Grant ($3,000).
With investigators from GW’s SMHS Dean’s office (Student Services, Diversity and Inclusion, and Admissions) and the Clinical and Translational Sciences Institute at Children’s National (CTSI-CN), sponsored a one-day Mentoring the Diverse Trainee Workshop. Interviewed first cohort of METEOR students.

7.  Principal investigator, March 2014 – May 2014 - 5% effort, in kind
GW Students for the Prevention of Jewish Genetic Diseases
Funded by Genzyme Corporation ($2,500).
Mentored pre-medicine student to conduct a university-wide screening of carrier status for genetic diseases prevalent in individuals of Jewish ancestry, as well as a half-day (1-5 pm) educational program regarding the prevention of Jewish genetic diseases at the GW Hillel.  


National Alpha Eta Honor Society, The George Washington University Chapter Inductee, June 2016

Early Career Women’s Leadership Seminar, American Association of Medical Colleges (AAMC), Invited Attendee, July 2012

Ralph O. Mueller Best Paper in Research Design, The George Washington University Graduate School of Education and Human Development Award recipient, February 2008

Outstanding Student Award, University of Pittsburgh Graduate School of Public Health, Award recipient, April 1992


HFR 8116: Academic and Clinical Leadership in the Health Professions
HSCI 6271: Research Methods for the Health Professional II                                           
HSCI 6261: Foundations in Translational Research                                                           
MLS 3001W: Professional Ethics for Medical Laboratory Scientists        
MLS 4171: Human Genetics     
MLS 6159: Leadership in Laboratory Medicine
MLS 6218:  Genetics       


Dr. Schwartz's research interest focuses on health professional advising and development.  She co-led a national, qualitative study of mentored to independent investigator transition.  She is also a member of a collaborative team of investigators developing a psychometric tool to measure individual collaboration readiness. She has published her work on a program for interprofessional communication for students in the Post-bac Pre-med Program and Accelerated Bachelor of Science in Nursing (ABSN) Program conducted with faculty members in the GW School of Nursing and an industry coach in GW's Center for Career Services. 

Community Service

  • Vice Chair (2021-2022), School of Medicine and Health Sciences Executive Committee, 2020-present
  • Member, University Hearing Board, 2019 - present
  • Member, Faculty Senate Committee on Education Policy and Technology, 2018 – present
  • Member, Benefits Advisory Committee, 2020-present
  • Chair (2021-2023), Member-at-large (2019-2021) Executive Committee, GW Clara Bliss Hinds Women in Medicine and Science (WIMS) Society, 2019 – present
  • Chair (2020-2022), Vice Chair (2019-2020), Health Sciences Student Evaluation Committee, 2018-present
  • Admissions Committee (Member), PhD in Translational Health Sciences, January 2016 – present
  • Reviewer/Site Visitor, Accreditation Council for Genetic Counseling (ACGC), 2020-present
  • National Association of Advisors for the Health Professions (NAAHP), 2014 – present
  • Executive Board Member (2018-2021), Northeast Association of Advisors for the Health Professions (NEAAHP), 2014-present              


  • Clinical and Translational Research
  • Medical Laboratory Sciences
  • Translational Health Sciences


View publications by this faculty member.

Industry Relationships and Collaborations

This faculty member (or a member of their immediate family) has reported a financial interest with the health care related companies listed below. These relations have been reported to the University and, when appropriate, management plans are in place to address potential conflicts.


Dr. Lisa Schwartz, Critic of Medical Excess, Is Dead at 55

Dr. Lisa Schwartz in 2017. She and her husband, Dr. Steven Woloshin, trained hundreds of journalists to become more skeptical about claimed scientific breakthroughs and miracle cures.

Dr. Lisa Schwartz, who with her husband devoted her life to warning patients about the dangers of unnecessary medical tests and treatment and excessive diagnoses, died on Nov. 29 in Lebanon, N.H. She was 55.

Her husband, Dr. Steven Woloshin, said the cause was cancer.

Dr. Schwartz and Dr. Woloshin were the directors of the Center for Medicine and Media at the Dartmouth Institute for Health Policy and Clinical Practice, part of Dartmouth College’s Geisel School of Medicine. There they trained hundreds of journalists to become more skeptical about claimed scientific breakthroughs and miracle cures, and to better communicate the benefits and risks of medical tests and treatments.

They often collaborated with another Dartmouth colleague, Dr. H. Gilbert Welch, on books and articles — for laymen and medical professionals alike — that aimed to demystify the credible risks of getting diseases. Their research helped the National Cancer Institute to develop the Know Your Chances website.

They lobbied the Food and Drug Administration to require that prescription medicine be labeled with a “drug facts box,” which would list the benefits and harms detected in clinical trials. The agency has been considering the proposal.

“We want doctors, the public and policymakers to know what they can and cannot get from various medications, treatments and interventions, so people can make wise decisions,” Dr. Schwartz told the college publication Dartmouth Medicine in 2012.

Last year, Dr. Schwartz and Dr. Woloshin received the John P. McGovern Award from the American Medical Writers Association. The award recognized their success in illuminating “the trade-offs between too little diagnosis (missing problems that might benefit from earlier treatment) and overdiagnosis (harming people with problems that never needed to be found).”

They saw what they called overdiagnosing as a consequence of advanced technology for detecting abnormalities and of lower thresholds, set by expert panels, for defining diseases.

“More diagnoses mean more money for drug manufacturers, hospitals, physicians and disease advocacy groups,” Dr. Schwartz, Dr. Woloshin and Dr. Welch wrote in an essay in The New York Times in 2007. “While failing to make a diagnosis can result in lawsuits, there are no corresponding penalties for overdiagnosis.”

They warned of “the medicalization of everyday life” and an “epidemic of diagnoses.”

“Everyday experiences like insomnia, sadness, twitchy legs and impaired sex drive now become diagnoses: sleep disorder, depression, restless leg syndrome and sexual dysfunction,” the doctors wrote.

They were particularly concerned about how such diagnoses affected children.

“If children cough after exercising, they have asthma; if they have trouble reading, they are dyslexic; if they are unhappy, they are depressed; and if they alternate between unhappiness and liveliness, they have bipolar disorder,” the doctors wrote.

“While these diagnoses may benefit the few with severe symptoms,” they added, “one has to wonder about the effect on the many whose symptoms are mild, intermittent or transient.”

They concluded, “If more than half of us are sick, what does it mean to be normal?”

Not surprising, their crusade had its critics. When they complained that a drug for restless leg syndrome was being overprescribed, the manufacturer, GlaxoSmithKline, responded that its advertising recommended that patients try other measures first. “There’s important information on our product label to inform physicians as to whether or not a product is appropriate,” the company said.

Lisa Miriam Schwartz was born in the Bronx on June 30, 1963, to Leonard Schwartz, an electrical engineer, and Heda (Teitcher) Schwartz, a vocational rehabilitation counselor.

She graduated from Montville High School in New Jersey and earned a bachelor’s degree in chemistry from the State University of New York at Binghamton (now Binghamton University) in 1985 and a medical degree in 1989 from the New York University School of Medicine.

She and Dr. Woloshin met in 1990 as medical residents at Bellevue Hospital Center in Manhattan.

Working at city-run clinics on the Lower East Side and in Chinatown, they got their first glimpse of the mismatch between the treatment being offered and the pool of potential patients: While the clinics were equipped with high-tech diagnostic equipment, they employed no interpreters for their clients, nearly all of whom were recent immigrants who spoke little English.

The couple married in 1992 and accepted a research fellowship two years later at Dartmouth, where Dr. Schwartz received a master of science degree and where they became professors of medicine and research partners.

In addition to her husband, Dr. Schwartz is survived by their daughter, Emma; their son, Eli; her mother; her brother, Mark; and her sister, Susan Schwartz.

In 2011, Dr. Schwartz and her husband were named directors of the Center for Medicine and Media, which is supported by, among others, the National Institutes of Health. She, Dr. Woloshin and Dr. Welch collaborated on the books “Know Your Chances” (2009) and “Overdiagnosed: Making People Sick in the Pursuit of Health” (2011).

“Lisa never lost her capacity to be truly angry about corruption, misinformation and lack of scientific rigor in the system,” Robert E. Drake, a fellow Geisel School professor, said in his eulogy.

Dr. Schwartz warned that too many people were being treated on the basis of CT scans even though, she said, the scans cannot distinguish a progressive cancer from a nonprogressive one. In 1999, she criticized the imminent issue of a postage stamp that said “Prostate Cancer Awareness: Annual Checkups and Tests.”

“How was it,” she later recalled wondering, “that the Postal Service was making screening recommendations?”

If everyone took the recommended tests for blood cholesterol and sugar, body mass index and diabetes, she once calculated, three in four adults in the United States would be classified as diseased.

As for her own illness, Dr. Schwartz received an accurate diagnosis and coped with seven years of uncertainty as she underwent several versions of chemotherapy.

“She did everything she could,” Dr. Welch said in an email. “More important, she would want patients to understand that good people — doing all the right things — can nonetheless develop bad diseases.”


Md lisa schwartz

Selected Publications

King-Dowling S, O'Hagan B, Faust H, Pai A, Freyer D, Szalda D, Barakat L, Hobbie W, Ginsberg J, Schwartz L : Correlates of meeting the strength-based and combined physical activity guidelines in adolescent and young adult survivors of childhood cancer. International Society of Pediatric Oncology (SIOP) Virtual Congress October 2021.

Darabos K, Li Y, O'Hagan B, King-Dowling S, Juberlirer T, Barakat LP, Schwartz LA: Trajectories and associates of pain severity and interference among adolescent and young adults with cancer. 2021 Annual Meeting of the Pediatric Academic Societies (virtual) May 2021.

Leahy AB, Schwartz LA, Li Y, Reeve BB, Bekelman JE, Aplenc R, Basch E : Electronic symptom monitoring in pediatric patients hospitalized for chemotherapy. Cancer Page: online, May 2021.

McDonald JA, Cherubina S, Goldberg M, Weib Y, Chung W, Schwartz L, Knight J, Schooling M, Santellah R, Bradbury A, Buys S, Andrulis I, John E, Daly M, Terry MBT: Common childhood viruses and pubertal timing: The LEGACY Girls Study. American Journal of Epidemiology 190(5): 766-778, May 2021.

McGrady ME, Mara CA, Geiger-Behm K, Ragsdale J, Davies S M, Schwartz LA, Phipps S, & Pai A L H. : Psychometric evaluation of the Brief RCOPE and relationships with psychological functioning among caregivers of children undergoing hematopoietic stem cell transplant. Psycho-Oncology Page: epub ahead of print, April 2021.

King-Dowling S, Psihogios AM, Bressler SN, Madden R, Ahmed A, O'Hagan B, Faust H, Barakat LP, Schwartz LA: The psychosocial impact of COVID-19 on adolescents and young adults with a history of cancer and their caregivers. Society of Pediatric Psychology Annual Conference April 2021.

Bressler S, Faust H, Macfarland S, Zelley K, Jennings S, King-Dowling S, Darabos K, Brodeur G, Schwartz LA: Perceived Child Cancer risk and distress among caregivers of children undergoing genetic testing for a cancer predisposition. Society of Pediatric Psychology Annual Conference (Virtual) April 2021.

Prussien K, Barakat L, Tucker C, Darabos K, King-Dowling S, O'Hagan B, Hobbie W, Ginsberg J, Szalda D, Schwartz LA: Sociodemographic disadvantage and healthcare satisfaction in relation to transition expectations and goals in young adult survivors of childhood cancer. Society of Pediatric Psychology Annual Conference (Vitual) April 2021.

Psihogios AM, King-Dowling S, O'Hagan B, Darabos K, Maurer L, Young J, Fleisher L, Barakat LP, Szalda D, Hill-Kayser CE, Schwartz LA : Contextual predictors of engagement in a tailored mHealth intervention for adolescent and young adult cancer. Annals of Behavioral Medicine Page: epub ahead of print, March 2021.

Wood J, King-Dowling S, Darabos K, Schwartz LA : Associations between health perceptions, distress, and adherence to survivorship self-management recommendations among adolescent & young adult survivors of childhood cancer 18th Annual American Psychosocial Oncology Society virtual conference March 2021.

back to top
Last updated: 07/18/2021
The Trustees of the University of Pennsylvania

Sours: //
10 11Why do some breast cancer patients get chemotherapy before surgery

Lisa Schwartz (physician)

For the YouTube personality and actress, see Lisa Schwartz.

Lisa M. Schwartz (June 30, 1963, in New York City - November 29, 2018, in Lebanon, NH)[1] was a Professor of Medicine and Community and Family Medicine at The Dartmouth Institute for Health Policy and Clinical Practice. She was the co-Director of the Center for Medicine and the Media, and ran courses for health journalists on how to report medical research. She created the Drug Facts Box to discuss the benefits and harms of prescription drugs and the National Cancer InstituteKnow Your Chances site to communicate cancer risks.

Early life and education[edit]

Schwartz was born in The Bronx borough of New York City.[1] She graduated from State University of New York in 1985.[2] She was part of the Phi Beta Kappa honor society.[citation needed] She earned her MD at the New York University in 1989.[2] She studied medicine at the Geisel School of Medicine and graduated in 1996.[2] She completed her residency at the Bellevue Hospital and was an internal medicine fellow at the Geisel School of Medicine.[2]


Schwartz collaborated extensively with her husband, Steven Woloshin. They worked to improve dialogue between physicians, the public and journalists, by improving transparency and understanding of medical evidence. They investigated the advertisements of prescription drugs in America.[3] In 2006 Woloshin and Schwartz systematically evaluated media coverage of medical meetings in The Medical Journal of Australia.[4] They considered 187 studies, finding that 34% did not mention the size of the study and 40% did not quantify the main result.[4] The study emphasised that articles presented at scientific meetings are not ready for the general public.[5] She published a monograph on health statistic communication with the Association for Psychological Science.[6] She was made the Director of the Center for Medicine in the Media in 2011. She investigated the advertisement of Alzheimer's disease drug donepezil, and demonstrated that the Food and Drug Administration permitted the advertisement without any evidence.[7] With Woloshin, she identified ways to overcome the overuse of medication.[8]

Schwartz studied how numeracy impacted a woman's ability to understand the benefit of cancer screening.[9] She launched the Know Your Chances with the National Cancer Institute to communicate cancer risks. It used data from SEET (Surveillance, Epidemiology and End Results Program) and the National Center for Health Statistics and included interactive charts that revealed the chances of dying.[10] They looked at whether women would accept more infrequent cervical smears. In 2013 she created Drugs Fact Box[11] with the Food and Drug Administration, a toolbox which could be used to communicate the benefits and cons of using prescription drugs.[12] The Drugs Fact Box was accompanied by a booklet that helped the public understand health statistics.[13] It was included in Section 3507 of the Patient Protection and Affordable Care Act.[14]

She led the National Institutes of HealthMedicine in the Media workshop and taught over five hundred health journalists how to understand medical research.[15] She co-authored Know Your Chances with Steven Woloshin in 2009 and Overdiagnosed in 2011.[16][17] She was awarded the McGovern Award from the American Medical Writers Association in 2017.[18] She has written for The New York Times, The Boston GlobeThe Washington Post and the Los Angeles Times.[19][20][21]

Personal life and death[edit]

Schwartz died of cancer[1] on 29 November 2018.[22]


  1. ^ abcMarcus, Adam (2019). "Lisa M Schwartz". The Lancet. 393 (10170): 400. doi:10.1016/S0140-6736(19)30150-3.
  2. ^ abcd"Faculty Expertise Database – Lisa Schwartz, MD – Geisel School of Medicine at Dartmouth". Retrieved 2018-12-03.
  3. ^Woloshin, Steven; Schwartz, Lisa M; Tremmel, Jennifer; Welch, H Gilbert (October 2001). "Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?". The Lancet. 358 (9288): 1141–1146. doi:10.1016/S0140-6736(01)06254-7. ISSN 0140-6736. PMID 11597668. S2CID 23868940.
  4. ^ abWoloshin, Steven; Schwartz, Lisa M. (2006-06-05). "Media reporting on research presented at scientific meetings: more caution needed". The Medical Journal of Australia. 184 (11): 576–580. doi:10.5694/j.1326-5377.2006.tb00384.x. ISSN 0025-729X. PMID 16768666. S2CID 277988.
  5. ^Kotwani, Namrata (2007). "The Media Miss Key Points in Scientific Reporting". AMA Journal of Ethics. 9 (1): 188–192. doi:10.1001/virtualmentor.2007.9.3.jdsc1-0703. ISSN 2376-6980. PMID 23217929.
  6. ^Gigerenzer, Gerd; Gaissmaier, Wolfgang; Kurz-Milcke, Elke; Schwartz, Lisa M.; Woloshin, Steven (2007). "Helping Doctors and Patients Make Sense of Health Statistics". Psychological Science in the Public Interest. 8 (2): 53–96. doi:10.1111/j.1539-6053.2008.00033.x. ISSN 1529-1006. PMID 26161749.
  7. ^"Re: How the FDA forgot the evidence: the case of donepezil 23 mg". The BMJ. 2018-12-03.
  8. ^Woloshin, Steven; Schwartz, Lisa M. (2018-05-22). "Overcoming overuse: the way forward is not standing still—an essay by Steven Woloshin and Lisa M Schwartz". BMJ. 361: k2035. doi:10.1136/bmj.k2035. ISSN 0959-8138. PMID 29789307. S2CID 206918134.
  9. ^Schwartz, Lisa M. (1997-12-01). "The Role of Numeracy in Understanding the Benefit of Screening Mammography". Annals of Internal Medicine. 127 (11): 966–72. CiteSeerX doi:10.7326/0003-4819-127-11-199712010-00003. ISSN 0003-4819. PMID 9412301. S2CID 19412405.
  10. ^"About Us - Know Your Chances | SRP/DCCPS/NCI/NIH". Retrieved 2018-12-03.
  11. ^ Drugs Fact Box
  12. ^Schwartz, Lisa M.; Woloshin, Steven (2013-08-20). "The Drug Facts Box: Improving the communication of prescription drug information". Proceedings of the National Academy of Sciences of the United States of America. 110 (Suppl 3): 14069–14074. doi:10.1073/pnas.1214646110. ISSN 0027-8424. PMC 3752172. PMID 23942130.
  13. ^"Dartmouth Medicine Magazine :: Inside the Drug Facts Box". Retrieved 2018-12-03.
  14. ^"Implementation of Section 3507 of the Patient Protection and Affordable Care Act of 2010"(PDF). FDA. Retrieved 2018-12-04.
  15. ^"Lisa Schwartz – Too Much Medicine Symposium 2018 Helsinki". Too Much Medicine Symposium 2018 Helsinki. Retrieved 2018-12-03.
  16. ^Steve., Woloshin (2009). Know your chances : understanding health statistics. University of California Press. ISBN . OCLC 297222261.
  17. ^Gilbert., Welch, H. (2012). Overdiagnosed : making people sick in the pursuit of health. Random House, Inc. ISBN . OCLC 778042872.
  18. ^"Fellowship & Award Recipients - American Medical Writers Association". Retrieved 2018-12-03.
  19. ^"Sell a disease to sell a drug". Washington Post. Retrieved 2018-12-03.
  20. ^Woloshin, Steven; Schwartz, Lisa M. (2014-02-16). "'Low T' and the peril of medicating grumpy old men". Los Angeles Times. ISSN 0458-3035. Retrieved 2018-12-03.
  21. ^Welch, Steven Woloshin, Lisa Schwartz and H. Gilbert. "Warned, but Worse Off". Retrieved 2018-12-03.
  22. ^"Lisa M. Schwartz Obituary". Valley news. December 2018.

Now discussing:

As it turned out, her grandmother died four years ago and now she lives alone. Seeing the flowers, Lena and Ira kissed. Me on the cheek.

15738 15739 15740 15741 15742